1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Autonomous Cortisol Secretion: new trials by email Literature Review of Autonomous Cortisol Secretion trials Research Report on Autonomous Cortisol Secretion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metyrapone for Mild Autonomous Cortisol Secretion (MACS) Metyrapone - Autonomous Cortisol Secretion, Mild Autonomous Cortisol Secretion (MACS) | Phase 2 | Active not recruiting | Mayo Clinic | 30 | 2023-12-19 | 2026-09-25 |
ACTH Syndrome, Ectopic (1) · Adrenal Hyperplasia, Congenital (1) · Cushing Syndrome (1)
Adrenal Gland Diseases (1) · Adrenocortical Hyperfunction (1) · Adrenogenital Syndrome (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disorders of Sex Development (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Gonadal Disorders (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Neoplasms (1)
Metyrapone (1)
Mayo Clinic (1)
United States (1)
Irina Bancos, MD (1)